NEW YORK (GenomeWeb) – Interpace Diagnostics said today that its ThyGenX and ThyraMir molecular thyroid tests have received coverage from four additional Blue Cross Blue Shield plans.
NEW YORK (GenomeWeb) – Interpace Diagnostics said today that its ThyGenX and ThyraMir molecular thyroid tests have received coverage from four additional Blue Cross Blue Shield plans.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?
Login Now.
Don't have a GenomeWeb or 360Dx account?
Register for Free.
Privacy Policy. Terms & Conditions. . Copyright © 2021 GenomeWeb, a business unit of Crain Communications. All Rights Reserved.